Anticancer gene therapy (MediGene)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnticancer gene therapy (MediGene)
Drug Alias NameMageA1-TCR gene therapy (MediGene)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionGene transferenceMelanoma-associated antigen 1 modulators
TargetsMelanoma-associated antigen 1
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesMedigene Ag
China Registration ClassN/A

Develop Information

Active CompaniesMedigene Ag
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A